Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/23618
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | LEMOINE, Lieselotte | - |
dc.contributor.author | Sugarbaker, Paul | - |
dc.contributor.author | VAN DER SPEETEN, Kurt | - |
dc.date.accessioned | 2017-05-11T09:18:43Z | - |
dc.date.available | 2017-05-11T09:18:43Z | - |
dc.date.issued | 2017 | - |
dc.identifier.citation | INTERNATIONAL JOURNAL OF HYPERTHERMIA, 33 (5), p. 582-592 | - |
dc.identifier.issn | 0265-6736 | - |
dc.identifier.uri | http://hdl.handle.net/1942/23618 | - |
dc.description.abstract | Peritoneal surface malignancy (PSM) is a common manifestation of digestive and gynecologic malignancies alike. At present, patients with isolated PSM are treated with a combination therapy of cytoreductive surgery (CRS) and hyperthermic peroperative intraperitoneal chemotherapy (HIPEC). The combination of CRS and intraperitoneal (IP) chemotherapy should now be considered standard of care for PSM from appendiceal epithelial cancers, colorectal cancer and peritoneal mesothelioma. Although there is a near universal standardization regarding the CRS, we are still lacking a much-needed standardization amongst the various IP chemotherapy treatment modalities used today in clinical practice. Pharmacologic evidence should be generated to answer important questions raised by the myriad of variables associated with IP chemotherapy. | - |
dc.language.iso | en | - |
dc.subject.other | peritoneal surface malignancy; HIPEC; EPIC; BIC | - |
dc.title | Drugs, doses, and durations of intraperitoneal chemotherapy: standardizing HIPEC and EPIC for colorectal, appendiceal, gastric, ovarian peritoneal surface malignancies and peritoneal mesothelioma. | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 592 | - |
dc.identifier.issue | 5 | - |
dc.identifier.spage | 582 | - |
dc.identifier.volume | 33 | - |
local.bibliographicCitation.jcat | A1 | - |
dc.description.notes | Van der Speeten, K (reprint author), Ziekenhuis Oost Limburg, Dept Surg Oncol, Schiepse Bos 6, B-3600 Genk, Belgium kurt.vanderspeeten@zol.be | - |
local.type.refereed | Refereed | - |
local.type.specified | Review | - |
local.bibliographicCitation.status | In Press | - |
dc.identifier.doi | 10.1080/02656736.2017.1291999 | - |
dc.identifier.isi | 000404780700014 | - |
item.contributor | LEMOINE, Lieselotte | - |
item.contributor | Sugarbaker, Paul | - |
item.contributor | VAN DER SPEETEN, Kurt | - |
item.validation | ecoom 2018 | - |
item.fullcitation | LEMOINE, Lieselotte; Sugarbaker, Paul & VAN DER SPEETEN, Kurt (2017) Drugs, doses, and durations of intraperitoneal chemotherapy: standardizing HIPEC and EPIC for colorectal, appendiceal, gastric, ovarian peritoneal surface malignancies and peritoneal mesothelioma.. In: INTERNATIONAL JOURNAL OF HYPERTHERMIA, 33 (5), p. 582-592. | - |
item.accessRights | Open Access | - |
item.fulltext | With Fulltext | - |
crisitem.journal.issn | 0265-6736 | - |
crisitem.journal.eissn | 1464-5157 | - |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Drugs doses and durations of intraperitoneal chemotherapy standardizing HIPEC and EPIC for colorectal appendiceal gastric ovarian peritoneal surface.pdf | Peer-reviewed author version | 1.11 MB | Adobe PDF | View/Open |
SCOPUSTM
Citations
14
checked on Sep 5, 2020
WEB OF SCIENCETM
Citations
46
checked on Apr 22, 2024
Page view(s)
32
checked on Sep 7, 2022
Download(s)
14
checked on Sep 7, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.